PYPD Competitors & Alternatives

Compare PolyPid with similar stocks in the same industry

Biotechnology

PYPD

Main Stock
$6.44
+4.63%
Tradestie Score
31
Market Cap
$53.57M
Analyst Upside
+78.7%

Supply-Chain & Ecosystem Map (Customers, Suppliers & Direct Competitors)

Bottleneck Score: 2/10 Drug Discovery Biotech Drug Delivery
Competitive Moat: None
Core Technology Stack: PLEX polymer-lipid matrix, local antibiotic delivery
Major Customers 3
hospitals surgical centers healthcare providers
Critical Suppliers 2
contract manufacturers API suppliers
Direct Ecosystem Rivals 0
Sole-source / monopoly positioning in sub-sector.

Top Competitors

218 stocks in Biotechnology
Company Price Market Cap P/E Score Action
FBRX Forte Biosciences, Inc. Common Stock
$76.99
+0.03%
$180.53M - 54 Compare
ACHV Achieve Life Sciences, Inc.
$6.78
+0.89%
$158.43M - 56 Compare
NVCT Nuvectis Pharma, Inc. Common Stock
$19.18
+0.37%
$154.27M - 54 Compare
OBIO Orchestra BioMed Holdings, Inc. Ordinary Shares
$7.07
-0.70%
$137.59M - 37 Compare
CLYM Climb Bio, Inc. Common Stock
$9.63
-3.12%
$133.50M - 45 Compare
SRZN Surrozen, Inc. Common
$30.16
-6.68%
$117.07M - 33 Compare
ANRO Alto Neuroscience Inc.
$25.11
-7.41%
$110.20M - 34 Compare
ENTX Entera Bio Ltd. Ordinary Shares
$3.03
+0.17%
$84.52M - 53 Compare
CNTB Connect Biopharma Holdings Limited Ordinary Shares
$0.61
-5.07%
$83.60M - 40 Compare
SLGL Sol-Gel Technologies Ltd. Ordinary Shares
$52.72
-4.08%
$82.18M - 41 Compare

Data updated: Nov 17, 2026 | Industry: Biotechnology (SIC 3841)

218 stocks in this industry